OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
Yawen Cai, Yuhui Chai, Yu Fu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Targeting NLRP3 inflammasome for neurodegenerative disorders
Jing Yao, Zhe Wang, Weihong Song, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 11, pp. 4512-4527
Closed Access | Times Cited: 32

Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases
Ying‐Hao Han, Xiaodong Liu, Meihua Jin, et al.
Inflammation Research (2023) Vol. 72, Iss. 9, pp. 1839-1859
Closed Access | Times Cited: 26

Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?
Adrianna Gielecińska, Mateusz Kciuk, Esam Bashir Yahya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189024-189024
Open Access | Times Cited: 26

Exercise improves cognitive dysfunction and neuroinflammation in mice through Histone H3 lactylation in microglia
Hao Han, Yawei Zhao, Junda Du, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 25

Role of pyroptosis in the pathogenesis and treatment of diseases
Xiangyu Jin, Yinchu Ma, Didi Liu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 23

Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management
Yueyue Guan, Guo-hua Tang, Lei Li, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 2, pp. 146-164
Open Access | Times Cited: 13

Mechanism of astragaloside IV regulating NLRP3 through LOC102555978 to attenuate cerebral ischemia reperfusion induced microglia pyroptosis
Ping Gao, Haowei Shi, Xiaofei Jin, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111862-111862
Closed Access | Times Cited: 7

Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer’s disease
Yanxin Shen, Guimei Zhang, Chunxiao Wei, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 3, pp. 613-631
Open Access | Times Cited: 7

Pharmacological effects of salidroside on central nervous system diseases
Meihua Jin, Chun Wang, Yifeng Xu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113746-113746
Closed Access | Times Cited: 35

Mechanism of pyroptosis in neurodegenerative diseases and its therapeutic potential by traditional Chinese medicine
Yanfang Liao, Xue Wang, Liting Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18

Friend or foe: role of pathological tau in neuronal death
Moxin Wu, Zhiying Chen, Min Jiang, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2215-2227
Closed Access | Times Cited: 16

The research trends and hotspots of NLRP3 inflammasome in Alzheimer's disease: a bibliometric and visualization analysis
Xuanwei Wen, Huiye Yang, Shuangxi Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases
Dan Chen, Yun Sun
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 1
Open Access

Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease
Zhonghua Li, Zhenqiang Zhang, Bin Yu
Journal of Medicinal Chemistry (2025)
Closed Access

Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease
Gustavo Basurto‐Islas, Mario Dı́az, Lizeth M. Zavala Ocampo, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access

Salidroside: Diverse Synthetic Pathways and Recent Advances in Pharmacological Effects Across Multiple Systems
Min Zhao, Liuxiang Feng, Wenhua Li
Pharmacological Research - Natural Products (2025), pp. 100176-100176
Closed Access

Isoliensinine ameliorates cognitive dysfunction in AlCl3/D-gal-induced Alzheimer’s disease-like mice by inhibiting the calcium signaling pathway
Jin-Qiu Li, Xiao-Han Ma, Hui Dai, et al.
Journal of Ethnopharmacology (2025), pp. 119567-119567
Closed Access

Harnessing Animal Studies to Uncover Pyroptosis Mechanisms in Alzheimer’s Disease: A Systematic Review Protocol
Amirul Hafiz Ahmad Abdullah, Nurul Farhana Jufri, Siti Fathiah Masre, et al.
Advances in Human Biology (2025)
Open Access

Natural products modulating MAPK for CRC treatment: a promising strategy
Lin Zhou, Jinlong Zhang, Kangning Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Research progress in traditional Chinese medicine in the treatment of Alzheimer’s disease and related dementias
Wanying Tan, Lingjun Qi, Xiaoyu Hu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24

Research progress of NLRP3 inflammasome and its inhibitors with aging diseases
Zhuo Yuan, Dongke Yu, Tingting Gou, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175931-175931
Open Access | Times Cited: 14

Pyroptosis in neurodegenerative diseases: from bench to bedside
Kejia Wu, Wan-rong Wang, Qian-hui Cheng, et al.
Cell Biology and Toxicology (2023) Vol. 39, Iss. 6, pp. 2467-2499
Closed Access | Times Cited: 14

Page 1 - Next Page

Scroll to top